Consuming too much salt has long been recognized as a primary threat to cardiovascular health, primarily due to its well-documented link to hypertension. However, a growing body of scientific research indicates that the consequences of a high-sodium diet extend far beyond elevated blood pressure, potentially reaching into the brain to interfere with memory, complex thinking, and emotional well-being. As public health officials continue to battle the widespread societal impacts of excessive salt intake, discovering novel therapeutic strategies or dietary interventions to mitigate this damage has become a matter of urgent scientific priority.
Now, a team of researchers in Japan has identified a promising candidate in LPC70, a specialized compound derived from soybeans. Earlier exploratory studies revealed that this unique ingredient possessed the capability to reduce both high blood pressure and cognitive impairments linked to a high-salt diet in experimental animal models. Building upon those initial observations, a new, more detailed investigation has taken a deeper dive into the exact cellular mechanisms at play. The findings reveal that the soy compound exerts a profound and targeted influence over vital chemical signaling pathways operating within both the kidneys and the brain, offering a clearer picture of how dietary interventions might one day counteract the systemic toll of excessive sodium.
How a Soy Compound May Counter the Effects of Excess Salt
At the core of the new research is a detailed examination of prostaglandins, a diverse family of local signaling molecules manufactured within the body from arachidonic acid, a fundamental fatty acid. These substances operate much like localized hormones, stepping in to orchestrate and regulate an array of essential physiological functions across multiple organ systems.
Within the cardiovascular network, prostaglandins play a critical role in controlling blood pressure by continuously balancing the widening and narrowing of blood vessels. Their operational footprint within the central nervous system, however, is considerably more complex. Depending on the precise cellular receptors they choose to activate, prostaglandins can trigger signals that either protect vulnerable nerve cells or instigate harmful inflammatory processes. In the brain, these divergent pathways have the potential to directly influence memory retention, cognitive processing, and emotional responses.
LPC70 itself is a specific form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine, which accounts for more than 70 percent of its total phospholipid content. Although previous laboratory experiments demonstrated that LPC70 could successfully ease salt-induced hypertension and cognitive difficulties, scientists had not yet fully unlocked the precise biochemical mechanisms responsible for these protective properties, particularly how the compound modulates prostaglandin signaling.
To resolve these lingering questions, a collaborative research team initiated a rigorous investigation into how LPC70 affects these intricate signaling pathways in mice maintained on a high-salt diet. The research was led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close partnership with Dr. Kazuhiro Kagotani.
Dr. Kubota, who served as the study’s first author, was instrumental in executing the daily experiments. His responsibilities included carefully measuring blood pressure fluctuations, monitoring subtle behavioral adaptations, and conducting deep molecular analyses of prostaglandin activity. His exhaustive work helped clarify how LPC70 manages to produce distinct, organ-specific effects in the precise physiological systems most vulnerable to salt-induced damage.
The academic leadership behind the project hails from prominent institutions in Japan. Prof. Mouri and Dr. Kubota are affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, as well as the International Center for Brain Science at Fujita Health University. Meanwhile, Dr. Kagotani brings industry and academic perspective through his affiliations with Tsuji Oil Mills Co., Ltd. and the Tsuji Health and Beauty Science Laboratory at Mie University.
The comprehensive findings from their collaborative efforts were released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Prof. Mouri, elaborating on the motivations driving the research. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," he added.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, mice subjected to a high-salt diet quickly developed pronounced, elevated blood pressure. However, true to the growing scientific understanding of sodium toxicity, the negative consequences quickly extended far beyond basic cardiovascular metrics.
The experimental animals subjected to the high-salt regimen also demonstrated marked changes in behavior. They became noticeably less socially interactive and experienced distinct difficulties when attempting to recognize objects they had encountered previously, signaling clear impairments in recognition memory. Interestingly, the mice retained normal general movement levels, and tests measuring anxiety-like behaviors revealed no substantial changes. This specific pattern strongly suggests that excessive dietary salt selectively disrupts complex cognitive and social neurological functions rather than triggering a generalized, widespread behavioral impairment across the board.
When the researchers introduced LPC70 as a dietary supplement to these salt-loaded mice, a significant reversal of these negative outcomes was observed. The animals experienced measurable improvements in blood pressure, bringing readings down from their elevated states, and simultaneously performed significantly better on standardized laboratory tests evaluating social interaction and object recognition memory.
These encouraging macroscopic improvements provided the necessary momentum for the research team to look deeper, prompting a comprehensive investigation into the microscopic chemical changes occurring within the internal organs of the test subjects.
Different Protective Effects in the Kidneys and Brain
To understand the divergent benefits observed in the animals, the scientists analyzed organ-specific tissue samples, beginning with the kidneys. In animals consuming a high-salt diet, researchers observed a marked increase in the expression of two key components involved in renal prostaglandin signaling: cyclooxygenase-2, widely known as COX-2, and the PGE2 receptor EP3. Both of these molecular actors are heavily implicated in driving the development of high hypertension associated with excessive salt consumption.
When mice received the soy-derived supplement, LPC70 successfully suppressed these salt-related increases. This suggested that the compound directly assists the body in correcting maladaptive signaling changes in the kidneys that would otherwise interfere with the body’s ability to properly regulate normal blood pressure.
A fundamentally different, yet equally compelling, response was uncovered when the team examined the prefrontal cortex, a critical region of the brain responsible for higher-order thinking, memory consolidation, and social behavior.
In this case, excess dietary salt reduced the expression of the PGD2 receptor DP1, a molecular structure that normally facilitates protective and anti-inflammatory signaling pathways inside the brain. Remarkably, the administration of LPC70 restored the expression levels of this beneficial receptor without altering DP2, a secondary receptor linked to potentially harmful, neurodegenerative inflammatory signals.
This nuanced distinction is considered vital by the research team because it demonstrates that LPC70 does not act as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, the compound exhibits a sophisticated, selective preference for signaling pathways that preserve and protect neurological tissue. This targeted restoration offers a plausible biological explanation for the tangible improvements in memory and social behavior recorded during the behavioral trials.
A Surprising Change in Chemical Signaling
In addition to mapping receptor expression, the research team uncovered an unexpected biochemical shift involving arachidonic acid, the essential fatty acid that serves as the biological building block for prostaglandin production.
Mice that consumed excess salt exhibited lower overall levels of circulating arachidonic acid in their systems. Yet, paradoxically, when those same salt-loaded mice were treated with LPC70, the concentrations of downstream prostaglandins derived from that fatty acid—including PGE2 and PGD2—actually increased.
This seemingly contradictory result suggests that LPC70 may optimize the body’s metabolic efficiency, helping tissues make better use of the limited available arachidonic acid to synthesize protective prostaglandins even under the metabolic stress of a high-salt environment.
When viewed as a unified whole, the data reveals a coordinated yet highly selective physiological response. In the renal system, LPC70 suppresses chemical pathways tied directly to hypertension. In the central nervous system, it selectively restores signaling networks designed to shield the brain from inflammation and cellular damage. Consequently, the compound’s protective efficacy is deeply dependent upon both the specific organ involved and the distinct subset of prostaglandin receptors being regulated.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
While the current findings are derived entirely from animal experiments and require substantial follow-up validation, they point toward a compelling future application. The data suggests that LPC70 could eventually be developed into a specialized functional food ingredient designed to buffer the human body against some of the more damaging systemic consequences of a high-sodium lifestyle.
The compound’s demonstrated capacity to simultaneously improve cardiovascular markers and cognitive performance in laboratory settings raises the intriguing possibility that natural dietary supplements could eventually be used to support both heart and brain health, particularly for populations where high-sodium diets are deeply entrenched in daily culture.
Nevertheless, researchers emphasize that clinical studies involving human participants remain an absolute prerequisite before any definitive claims can be made regarding translation to everyday human diets.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri, summarizing the broader implications of the work.
Ultimately, the study provides a significantly clearer scientific window into how a naturally derived soy compound can successfully modulate the body’s complex physiological responses to excessive dietary salt, opening up new horizons for nutritional science and long-term health preservation.
The research described in the study received vital financial backing through Grants-in-Aid for Scientific Research issued by the Japan Society for the Promotion of Science under reference numbers 20K07931, 22K07606, 22K11891, and 23H02843.
Additional financial support was furnished by the Fujita Mind-Brain Research & Innovation Center for Drug Generation through Japan’s Peak Research Universities Program under grant JPJS00420240019, alongside contributions from the Japan Science and Technology Agency FOREST Program under reference JPMJFR215H.
Direct funding for the research collaboration was also supplied by Tsuji Oil Mills Co., Ltd. Additional grants, facilities, and material support were provided by the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
